Collectively, these data demonstrate that the outcome of cancer cell exposure to CAP is defined in terms of its concentration, in association with the genetic background of a given cancer type, being especially relevant for the expression levels of TRPV6 and tNOX (as possible predictors of responsiveness) as well the phenotype TRPV1High (as a possible eligibility criterion). This evidence concerns the gene TRPV6 and cancer.